دورية أكاديمية
Prognostic Impact of Immune-Related Adverse Events as First-Line Therapy for Metastatic Renal Cell Carcinoma Treated With Nivolumab Plus Ipilimumab: A Multicenter Retrospective Study
العنوان: | Prognostic Impact of Immune-Related Adverse Events as First-Line Therapy for Metastatic Renal Cell Carcinoma Treated With Nivolumab Plus Ipilimumab: A Multicenter Retrospective Study |
---|---|
المؤلفون: | Nukaya, Takuhisa, Takahara, Kiyoshi, Yoshizawa, Atsuhiko, Saruta, Masanobu, Yano, Yusuke, Ohno, Takaya, Uchimoto, Taizo, Fukuokaya, Wataru, Adachi, Takahiro, Yamazaki, Shogo, Tokushige, Satoshi, Nishimura, Kazuki, Tsujino, Takuya, Nakamori, Keita, Yamamoto, Shutaro, Iwatani, Kosuke, Urabe, Fumihiko, Mori, Keiichiro, Yanagisawa, Takafumi, Tsuduki, Shunsuke, Hirasawa, Yosuke, Hashimoto, Takeshi, Komura, Kazumasa, Inamoto, Teruo, Miki, Jun, Kimura, Takahiro, Ohno, Yoshio, Azuma, Haruhito, Shiroki, Ryoichi |
المصدر: | In Clinical Genitourinary Cancer February 2024 22(1):76-83 |
قاعدة البيانات: | ScienceDirect |
كن أول من يترك تعليقا!